歌礼制药-B(01672)再涨超6%,截至发稿,涨5.52%,报17.2港元,成交额6945.8万港元。消息面上,GIC在歌礼制药最新一轮配售中获得头部分配额度,将助力ASC30加速全球III期临床推进。2月6日,港交所披露的信息显示,新加坡政府投资基金(GIC)以每股均价12.18港元的价格,斥资约7.81亿港元买入歌礼制药6412.8万股新股。交易完成后,GIC持有歌礼制药6.42%股权。...
Source Link歌礼制药-B(01672)再涨超6%,截至发稿,涨5.52%,报17.2港元,成交额6945.8万港元。消息面上,GIC在歌礼制药最新一轮配售中获得头部分配额度,将助力ASC30加速全球III期临床推进。2月6日,港交所披露的信息显示,新加坡政府投资基金(GIC)以每股均价12.18港元的价格,斥资约7.81亿港元买入歌礼制药6412.8万股新股。交易完成后,GIC持有歌礼制药6.42%股权。...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.